An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
Subscribe to France 24 now:
FRANCE 24 live news stream: all the latest news 24/7
Visit our website:
Subscribe to our YouTube channel:
Like us on Facebook:
Follow us on Twitter:
